GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Moelis & Co (NYSE:MC) » Definitions » Beneish M-Score

Moelis (Moelis) Beneish M-Score

: -2.54 (As of Today)
View and export this data going back to 2014. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.54 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Moelis's Beneish M-Score or its related term are showing as below:

MC' s Beneish M-Score Range Over the Past 10 Years
Min: -4.36   Med: -3.53   Max: -2.02
Current: -2.54

During the past 13 years, the highest Beneish M-Score of Moelis was -2.02. The lowest was -4.36. And the median was -3.53.


Moelis Beneish M-Score Historical Data

The historical data trend for Moelis's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moelis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.02 -2.91 -4.36 -2.03 -2.54

Moelis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.03 -2.66 -3.17 -3.08 -2.54

Competitive Comparison

For the Capital Markets subindustry, Moelis's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moelis Beneish M-Score Distribution

For the Capital Markets industry and Financial Services sector, Moelis's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Moelis's Beneish M-Score falls into.



Moelis Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Moelis for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.302+0.528 * 2.2747+0.404 * 0.9615+0.892 * 0.8675+0.115 * 1.0764
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.4645+4.679 * -0.16476-0.327 * 1.1122
=-2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $63.6 Mil.
Revenue was 214.878 + 272.179 + 179.871 + 187.82 = $854.7 Mil.
Gross Profit was 36.393 + 29.948 + 34.077 + 39.581 = $140.0 Mil.
Total Current Assets was $250.9 Mil.
Total Assets was $1,179.8 Mil.
Property, Plant and Equipment(Net PPE) was $235.8 Mil.
Depreciation, Depletion and Amortization(DDA) was $8.3 Mil.
Selling, General, & Admin. Expense(SGA) was $107.4 Mil.
Total Current Liabilities was $601.6 Mil.
Long-Term Debt & Capital Lease Obligation was $215.7 Mil.
Net Income was -5.66 + -10.732 + -11.974 + 3.666 = $-24.7 Mil.
Non Operating Income was 5.145 + 9.943 + -5.629 + 1.746 = $11.2 Mil.
Cash Flow from Operations was 99.337 + 140.123 + 71.155 + -152.143 = $158.5 Mil.
Total Receivables was $56.3 Mil.
Revenue was 207.183 + 233.506 + 242.52 + 302.088 = $985.3 Mil.
Gross Profit was 66.154 + 73.069 + 102.428 + 125.451 = $367.1 Mil.
Total Current Assets was $263.9 Mil.
Total Assets was $1,216.9 Mil.
Property, Plant and Equipment(Net PPE) was $209.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $8.0 Mil.
Selling, General, & Admin. Expense(SGA) was $84.5 Mil.
Total Current Liabilities was $565.2 Mil.
Long-Term Debt & Capital Lease Obligation was $192.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(63.635 / 854.748) / (56.339 / 985.297)
=0.074449 / 0.05718
=1.302

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(367.102 / 985.297) / (139.999 / 854.748)
=0.37258 / 0.16379
=2.2747

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (250.85 + 235.801) / 1179.759) / (1 - (263.878 + 209.493) / 1216.869)
=0.5875 / 0.610993
=0.9615

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=854.748 / 985.297
=0.8675

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.975 / (7.975 + 209.493)) / (8.317 / (8.317 + 235.801))
=0.036672 / 0.03407
=1.0764

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(107.382 / 854.748) / (84.524 / 985.297)
=0.12563 / 0.085785
=1.4645

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((215.684 + 601.613) / 1179.759) / ((192.762 + 565.169) / 1216.869)
=0.692766 / 0.622853
=1.1122

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-24.7 - 11.205 - 158.472) / 1179.759
=-0.16476

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Moelis has a M-score of -2.54 suggests that the company is unlikely to be a manipulator.


Moelis (Moelis) Business Description

Traded in Other Exchanges
Address
399 Park Avenue, 4th Floor, New York, NY, USA, 10022
Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
Executives
Kenneth Moelis director, 10 percent owner, officer: Chairman and CEO C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Ciafone Katherine Pilcher officer: Chief Operating Officer 399 PARK AVE, NEW YORK NY 10022
Kenneth Shropshire director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10011
Elizabeth Crain officer: Chief Operating Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Navid Mahmoodzadegan director, officer: Managing Director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Osamu R. Watanabe officer: General Counsel and Secretary C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Jeffrey Raich director, officer: Managing Director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Christopher Callesano officer: SVP & Principal Acct Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Laila Worrell director 399 PARK AVENUE, NEW YORK NY 10022
Joseph Simon officer: Chief Financial Officer C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Yolonda C Richardson director 399 PARK AVENUE, NEW YORK NY 10022
Leaman J Richard Iii director, officer: Managing Partner C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
John A Allison director PO BOX 1250, WINSTON SALEM NC 27102-1250
Yvonne Greenstreet director PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054
Eric Cantor director C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022